| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.35 | 7e-07 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |